Emcure Pharma IPO concludes with 68 times subscription; shares likely to debut on this date
Emcure Pharma IPO Final Day Subscription Update: Pune-headquartered Emcure Pharmaceuticals concluded an initial public offering (IPO) on Friday with a subscription of nearly 68 times the offered equity. The IPO, worth an estimated Rs 1,952 crore, was a combination of fresh issuance and an offer for sale (OFS). By the end of Friday, the final day of bidding which began on Wednesday, the IPO received bids for approximately 93 crore shares against the 1.4 crore shares on offer, according to provisional exchange data.
Emcure Pharmaceuticals is a drug maker headquartered in Pune. | File photo | Image: Pexels